ARCA biopharma, Inc. (NasdaqCM: ABIO)

Collapse
X
 
  • Saat
  • Show
Clear All
new posts
  • stockbroker
    Master
    • 28 Temmuz 2008
    • 4807

    #1

    ARCA biopharma, Inc. (NasdaqCM: ABIO)

    Company Profile:

    ARCA biopharma, Inc.
    8001 Arista Place
    Suite 200
    Broomfield, CO 80021
    United States - Map
    Phone: 720-940-2200
    Fax: 720-208-9261
    Website: http://www.arcabiopharma.com

    Details:


    Index Membership: N/A
    Sector: Healthcare
    Industry: Biotechnology
    Full Time Employees: 21

    Business Summary:

    ARCA biopharma, Inc., a biopharmaceutical company, engages in the development of genetically-targeted therapies for cardiovascular diseases. Its principal product candidate, Gencaro (bucindolol hydrochloride), is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure and also for the prevention of atrial fibrillation in patients with heart failure. The company has identified common genetic variations in the cardiovascular system that it believes interact with Gencaro’s pharmacology and may predict patient response. ARCA has collaboration with Laboratory Corporation of America to develop the Gencaro Test, a companion test for the genetic markers that identify these common genetic variations. The company is headquartered in Broomfield, Colorado.
Working...
X

Debug Information